IMO It is a good thing. The HIV cure was a bone marrow transplant used to cure types of blood Cancer that relates to people having GVHD that makes this HIV treatment more risky to have as what the experts are saying I believe. So if KALYTERA can prevent the GVHD this may make the HIV bone marrow transplants much easier to achieve and it can become more of a mainstream treatment to cure HIV. This could open up another market for KALYTERA and save more lives.